ImmunityBio, Inc.(IBRX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IBRX ImmunityBio, Inc.

交易中 07-15 10:39:48 EDT

2.79

-0.11

-3.72%

最高2.95	最低2.78	成交量170.73万
今开2.92	昨收2.90	日振幅5.86%
总市值24.64亿	流通市值3.66亿	总股本8.83亿
成交额488.96万	换手率1.30%	流通股本1.31亿
市净率-4.17	ROE78.05%	每股收益-0.58
52周最高7.48	52周最低1.83	市盈率-4.86
股息0.00	股息收益率0.00	ROA-55.61%

北京优虎网络科技有限公司

{"stockData":{"symbol":"IBRX","market":"US","secType":"STK","nameCN":"ImmunityBio, Inc.","latestPrice":2.795,"timestamp":1752590385830,"preClose":2.9,"halted":0,"volume":1687667,"delay":0,"floatShares":130922174,"shares":882620409,"eps":-0.575021,"marketStatus":"交易中","change":-0.105,"latestTime":"07-15 10:39:47 EDT","open":2.92,"high":2.95,"low":2.78,"amount":4835136.2520608,"amplitude":0.058621,"askPrice":2.8,"askSize":2748,"bidPrice":2.79,"bidSize":3815,"shortable":3,"etf":0,"ttmEps":-0.575021,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1752609600000},"marketStatusCode":2,"adr":0,"listingDate":1438056000000,"exchange":"NASDAQ","adjPreClose":2.9,"preHourTrading":{"tag":"盘前","latestPrice":2.91,"preClose":2.9,"latestTime":"09:28 EDT","volume":47524,"amount":138749.9821004,"timestamp":1752586080053},"postHourTrading":{"tag":"盘后","latestPrice":2.91,"preClose":2.9,"latestTime":"19:59 EDT","volume":36516,"amount":105930.6674,"timestamp":1752537559143},"volumeRatio":1.519968,"impliedVol":1.017,"impliedVolPercentile":0.504},"requestUrl":"/m/hq/s/IBRX","defaultTab":"news","newsList":[{"id":"2550664655","title":"Immunitybio, Inc.盘中异动 早盘大幅上涨5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550664655","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550664655?lang=zh_cn&edition=full","pubTime":"2025-07-09 21:42","pubTimestamp":1752068570,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日21时42分，Immunitybio, Inc.股票出现波动，股价大幅上涨5.16%。Immunitybio, Inc.股票所在的生物技术行业中，整体涨幅为1.18%。Immunitybio, Inc.公司简介：ImmunityBio Inc是一家综合性临床阶段生物技术公司，致力于发现、开发和商业化下一代免疫和细胞疗法，以增强自然免疫系统，从而驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709214250a4407e91&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709214250a4407e91&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBRX","BK4139"],"gpt_icon":0},{"id":"2549588905","title":"Immunitybio, Inc.盘中异动 早盘股价大涨6.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549588905","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549588905?lang=zh_cn&edition=full","pubTime":"2025-07-07 21:31","pubTimestamp":1751895102,"startTime":"0","endTime":"0","summary":"北京时间2025年07月07日21时31分，Immunitybio, Inc.股票出现异动，股价大幅上涨6.62%。Immunitybio, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。Immunitybio, Inc.公司简介：ImmunityBio Inc是一家综合性临床阶段生物技术公司，致力于发现、开发和商业化下一代免疫和细胞疗法，以增强自然免疫系统，从而驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707213142a43bf636&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707213142a43bf636&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IBRX"],"gpt_icon":0},{"id":"2548848883","title":"Immunitybio, Inc.盘中异动 早盘快速跳水5.11%报2.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548848883","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548848883?lang=zh_cn&edition=full","pubTime":"2025-07-01 23:11","pubTimestamp":1751382669,"startTime":"0","endTime":"0","summary":"北京时间2025年07月01日23时11分，Immunitybio, Inc.股票出现波动，股价快速下挫5.11%。Immunitybio, Inc.股票所在的生物技术行业中，整体涨幅为0.64%。Immunitybio, Inc.公司简介：ImmunityBio Inc是一家综合性临床阶段生物技术公司，致力于发现、开发和商业化下一代免疫和细胞疗法，以增强自然免疫系统，从而驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701231109a728b6ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701231109a728b6ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBRX","BK4139"],"gpt_icon":0},{"id":"2546249649","title":"Immunitybio, Inc.盘中异动 股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546249649","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546249649?lang=zh_cn&edition=full","pubTime":"2025-06-25 22:11","pubTimestamp":1750860680,"startTime":"0","endTime":"0","summary":"北京时间2025年06月25日22时11分，Immunitybio, Inc.股票出现异动，股价急速下挫5.02%。Immunitybio, Inc.股票所在的生物技术行业中，整体跌幅为0.80%。Immunitybio, Inc.公司简介：ImmunityBio Inc是一家综合性临床阶段生物技术公司，致力于发现、开发和商业化下一代免疫和细胞疗法，以增强自然免疫系统，从而驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625221120a71d3428&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625221120a71d3428&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IBRX"],"gpt_icon":0},{"id":"2544599523","title":"Immunitybio, Inc.盘中异动 股价大跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544599523","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544599523?lang=zh_cn&edition=full","pubTime":"2025-06-17 22:17","pubTimestamp":1750169821,"startTime":"0","endTime":"0","summary":"北京时间2025年06月17日22时17分，Immunitybio, Inc.股票出现异动，股价快速下挫5.11%。Immunitybio, Inc.股票所在的生物技术行业中，整体跌幅为0.80%。Immunitybio, Inc.公司简介：ImmunityBio Inc是一家综合性临床阶段生物技术公司，致力于发现、开发和商业化下一代免疫和细胞疗法，以增强自然免疫系统，从而驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617221701978383db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617221701978383db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IBRX"],"gpt_icon":1},{"id":"2543603713","title":"Immunitybio, Inc.盘中异动 快速拉升5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2543603713","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543603713?lang=zh_cn&edition=full","pubTime":"2025-06-16 21:54","pubTimestamp":1750082050,"startTime":"0","endTime":"0","summary":"北京时间2025年06月16日21时54分，Immunitybio, Inc.股票出现异动，股价快速拉升5.21%。Immunitybio, Inc.股票所在的生物技术行业中，整体跌幅为0.06%。Immunitybio, Inc.公司简介：ImmunityBio Inc是一家综合性临床阶段生物技术公司，致力于发现、开发和商业化下一代免疫和细胞疗法，以增强自然免疫系统，从而驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506162154109781f271&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506162154109781f271&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBRX","BK4139"],"gpt_icon":0},{"id":"2542380119","title":"Immunitybio, Inc.盘中异动 快速上涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542380119","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542380119?lang=zh_cn&edition=full","pubTime":"2025-06-09 21:35","pubTimestamp":1749476127,"startTime":"0","endTime":"0","summary":"北京时间2025年06月09日21时35分，Immunitybio, Inc.股票出现波动，股价大幅拉升5.08%。Immunitybio, Inc.股票所在的生物技术行业中，整体涨幅为0.29%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506092135279514d520&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506092135279514d520&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IBRX"],"gpt_icon":0},{"id":"2541590863","title":"Immunitybio, Inc.盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2541590863","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541590863?lang=zh_cn&edition=full","pubTime":"2025-06-06 21:33","pubTimestamp":1749216792,"startTime":"0","endTime":"0","summary":"北京时间2025年06月06日21时33分，Immunitybio, Inc.股票出现波动，股价快速拉升5.00%。截至发稿，该股报3.05美元/股，成交量24.6521万股，换手率0.03%，振幅2.07%。Immunitybio, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025060621331397747137&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025060621331397747137&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBRX","BK4139"],"gpt_icon":0},{"id":"2540067655","title":"Immunitybio, Inc.盘中异动 临近午盘快速上涨5.00%报2.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540067655","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540067655?lang=zh_cn&edition=full","pubTime":"2025-06-04 23:40","pubTimestamp":1749051613,"startTime":"0","endTime":"0","summary":"北京时间2025年06月04日23时40分，Immunitybio, Inc.股票出现异动，股价快速上涨5.00%。Immunitybio, Inc.股票所在的生物技术行业中，整体涨幅为0.87%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250604234014a49a19d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250604234014a49a19d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IBRX"],"gpt_icon":0},{"id":"2540474794","title":"ImmunityBio(IBRX.US)淋巴细胞减少症疗法Anktiva获FDA扩大使用授权","url":"https://stock-news.laohu8.com/highlight/detail?id=2540474794","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540474794?lang=zh_cn&edition=full","pubTime":"2025-06-03 14:50","pubTimestamp":1748933408,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，ImmunityBio周一表示，美国食品药品监督管理局已批准其 Cancer BioShield 平台扩大使用范围，用于治疗患有晚期或复发性实体瘤的成人患者的淋巴细胞减少症，不论肿瘤类型如何。该扩大准入将面向所有一线治疗后病情未见好转且绝对淋巴细胞计数水平较低的实体瘤患者开放。ImmunityBio 公司的 Anktiva 和 CAR-N 已获得美国食品药品监督管理局的再生医学先进疗法认定，用于逆转接受化疗或放疗标准治疗的患者以及复发性局部晚期或转移性胰腺癌患者的淋巴细胞减少症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1300600.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"ImmunityBio(IBRX.US)淋巴细胞减少症疗法Anktiva获FDA扩大使用授权","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4139","IBRX"],"gpt_icon":0},{"id":"2540725795","title":"Immunitybio, Inc.盘中异动 快速拉升6.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2540725795","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540725795?lang=zh_cn&edition=full","pubTime":"2025-06-02 21:31","pubTimestamp":1748871106,"startTime":"0","endTime":"0","summary":"北京时间2025年06月02日21时31分，Immunitybio, Inc.股票出现异动，股价大幅上涨6.02%。Immunitybio, Inc.股票所在的生物技术行业中，整体涨幅为0.26%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602213146a6f72358&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602213146a6f72358&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IBRX"],"gpt_icon":0},{"id":"2539109266","title":"Immunitybio, Inc.盘中异动 早盘大幅上涨5.08%报2.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2539109266","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539109266?lang=zh_cn&edition=full","pubTime":"2025-05-29 21:54","pubTimestamp":1748526874,"startTime":"0","endTime":"0","summary":"北京时间2025年05月29日21时54分，Immunitybio, Inc.股票出现波动，股价大幅上涨5.08%。截至发稿，该股报2.59美元/股，成交量62.2477万股，换手率0.07%，振幅4.88%。Immunitybio, Inc.股票所在的生物技术行业中，整体涨幅为0.54%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250529215434a49171eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250529215434a49171eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","IBRX","ALZN"],"gpt_icon":0},{"id":"2538647844","title":"Immunitybio, Inc.盘中异动 股价大涨8.30%报2.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2538647844","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538647844?lang=zh_cn&edition=full","pubTime":"2025-05-27 21:32","pubTimestamp":1748352759,"startTime":"0","endTime":"0","summary":"北京时间2025年05月27日21时32分，Immunitybio, Inc.股票出现波动，股价大幅上涨8.30%。截至发稿，该股报2.74美元/股，成交量79.8611万股，换手率0.09%，振幅3.16%。Immunitybio, Inc.股票所在的生物技术行业中，整体涨幅为0.76%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527213240a48e73cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527213240a48e73cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBRX","BK4139"],"gpt_icon":0},{"id":"2537022137","title":"Immunitybio, Inc.盘中异动 早盘股价大跌5.04%报2.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537022137","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537022137?lang=zh_cn&edition=full","pubTime":"2025-05-23 22:20","pubTimestamp":1748010055,"startTime":"0","endTime":"0","summary":"北京时间2025年05月23日22时20分，Immunitybio, Inc.股票出现异动，股价快速下跌5.04%。截至发稿，该股报2.55美元/股，成交量116.671万股，换手率0.13%，振幅2.94%。Immunitybio, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523222055aa2c985b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523222055aa2c985b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBRX","BK4139"],"gpt_icon":0},{"id":"2537958345","title":"Immunitybio, Inc.盘中异动 快速跳水5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537958345","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537958345?lang=zh_cn&edition=full","pubTime":"2025-05-22 00:56","pubTimestamp":1747846610,"startTime":"0","endTime":"0","summary":"北京时间2025年05月22日00时56分，Immunitybio, Inc.股票出现波动，股价快速跳水5.00%。Immunitybio, Inc.股票所在的生物技术行业中，整体跌幅为0.48%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522005650976100cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522005650976100cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IBRX"],"gpt_icon":0},{"id":"2536389376","title":"Immunitybio, Inc.盘中异动 快速下挫5.28%报2.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536389376","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536389376?lang=zh_cn&edition=full","pubTime":"2025-05-19 21:50","pubTimestamp":1747662641,"startTime":"0","endTime":"0","summary":"北京时间2025年05月19日21时50分，Immunitybio, Inc.股票出现异动，股价大幅下挫5.28%。Immunitybio, Inc.股票所在的生物技术行业中，整体跌幅为0.06%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519215041a6e4d526&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519215041a6e4d526&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBRX","BK4139"],"gpt_icon":0},{"id":"1190307410","title":"异动解读 | ImmunityBio夜盘大跌5.63%，Q1财报显示亏损持续","url":"https://stock-news.laohu8.com/highlight/detail?id=1190307410","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190307410?lang=zh_cn&edition=full","pubTime":"2025-05-19 08:14","pubTimestamp":1747613663,"startTime":"0","endTime":"0","summary":"ImmunityBio, Inc.在夜盘交易中股价大跌5.63%，引发市场关注。这家临床阶段生物科技公司今日早些时候公布了2025财年第一季度财务报告，显示公司仍面临巨额亏损。根据财报，ImmunityBio第一季度净亏损为1.30亿美元，虽然较去年同期略有改善，同比减少亏损2.99%，但仍然处于大幅亏损状态。从资产负债情况来看，ImmunityBio的财务状况仍然面临挑战。夜盘的大幅下跌可能反映了市场对公司财务状况的担忧，尽管具体原因还需进一步观察。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["IBRX"],"gpt_icon":0},{"id":"1116113688","title":"异动解读 | ImmunityBio夜盘大跌5.63%，Q1财报净亏损1.3亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1116113688","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116113688?lang=zh_cn&edition=full","pubTime":"2025-05-19 08:14","pubTimestamp":1747613662,"startTime":"0","endTime":"0","summary":"生物科技公司ImmunityBio在夜盘交易中股价大跌5.63%，引发市场关注。这一显著跌幅与公司最新发布的2025财年第一季度财务报告密切相关。根据ImmunityBio公布的财报，公司2025财年第一季度净亏损为1.30亿美元，虽然同比收窄2.99%，但仍然处于大幅亏损状态。每股基本亏损为0.15美元。尽管ImmunityBio的营收出现显著增长，但持续的亏损状况可能是导致投资者信心下降的主要原因。作为一家专注于开发下一代免疫和细胞疗法的临床阶段生物科技公司，ImmunityBio的研发投入可能仍然较高。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"异动解读 | ImmunityBio夜盘大跌5.63%，Q1财报净亏损1.3亿美元","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["IBRX"],"gpt_icon":0},{"id":"2535312596","title":"Immunitybio, Inc.盘中异动 大幅拉升5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535312596","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535312596?lang=zh_cn&edition=full","pubTime":"2025-05-16 22:19","pubTimestamp":1747405170,"startTime":"0","endTime":"0","summary":"北京时间2025年05月16日22时19分，Immunitybio, Inc.股票出现异动，股价急速上涨5.06%。Immunitybio, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516221930a481049e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516221930a481049e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IBRX"],"gpt_icon":0},{"id":"2535087333","title":"Immunitybio, Inc.盘中异动 大幅拉升5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535087333","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535087333?lang=zh_cn&edition=full","pubTime":"2025-05-16 00:03","pubTimestamp":1747325019,"startTime":"0","endTime":"0","summary":"北京时间2025年05月16日00时03分，Immunitybio, Inc.股票出现异动，股价大幅上涨5.42%。Immunitybio, Inc.股票所在的生物技术行业中，整体涨幅为1.60%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051600034094f8144d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051600034094f8144d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IBRX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.immunitybio.com","stockEarnings":[{"period":"1week","weight":0.0662},{"period":"1month","weight":-0.0554},{"period":"3month","weight":0.0432},{"period":"6month","weight":0.2134},{"period":"1year","weight":-0.5619},{"period":"ytd","weight":0.1328}],"compareEarnings":[{"period":"1week","weight":0.0067},{"period":"1month","weight":0.0466},{"period":"3month","weight":0.1622},{"period":"6month","weight":0.054},{"period":"1year","weight":0.1158},{"period":"ytd","weight":0.0661}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"ImmunityBio, Inc.于2002年10月7日在伊利诺伊州ZelleRx Corporation公司的名义下注册成立，于2010年1月22日，公司更名为Conkwest股份有限公司。ImmunityBio是一家领先的晚期免疫治疗公司，可激活先天和适应性免疫系统，以治疗肿瘤学和传染病领域内严重未满足的需求。公司是一家领先的临床剂型的现成自然杀伤细胞疗法生产商，记忆NK细胞，连同抗体细胞因子融合蛋白、白蛋白结合化学免疫调节剂和疫苗载体的综合平台。通过结合这些NK、巨噬细胞和T细胞激活平台，该公司相信ImmunityBio在免疫治疗领域处于领先地位，具有跨越多种肿瘤类型和传染病的后期临床开发。","yearOnYearQuotes":[{"month":1,"riseRate":0.3,"avgChangeRate":0.02541},{"month":2,"riseRate":0.5,"avgChangeRate":0.026818},{"month":3,"riseRate":0.3,"avgChangeRate":-0.083879},{"month":4,"riseRate":0.5,"avgChangeRate":0.021643},{"month":5,"riseRate":0.4,"avgChangeRate":0.054052},{"month":6,"riseRate":0.3,"avgChangeRate":0.132356},{"month":7,"riseRate":0.5,"avgChangeRate":-0.012572},{"month":8,"riseRate":0.3,"avgChangeRate":-0.116269},{"month":9,"riseRate":0.3,"avgChangeRate":-0.041956},{"month":10,"riseRate":0.5,"avgChangeRate":0.035321},{"month":11,"riseRate":0.7,"avgChangeRate":0.13572},{"month":12,"riseRate":0.4,"avgChangeRate":0.069947}],"exchange":"NASDAQ","name":"ImmunityBio, Inc.","nameEN":"ImmunityBio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ImmunityBio, Inc.(IBRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ImmunityBio, Inc.(IBRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ImmunityBio, Inc.,IBRX,ImmunityBio, Inc.股票,ImmunityBio, Inc.股票老虎,ImmunityBio, Inc.股票老虎国际,ImmunityBio, Inc.行情,ImmunityBio, Inc.股票行情,ImmunityBio, Inc.股价,ImmunityBio, Inc.股市,ImmunityBio, Inc.股票价格,ImmunityBio, Inc.股票交易,ImmunityBio, Inc.股票购买,ImmunityBio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ImmunityBio, Inc.(IBRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ImmunityBio, Inc.(IBRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}